Tropicamide
Dilation & diagnostic · Rx
RxDilation & diagnosticMydriatic Red cap
| Strength | 0.5%, 1% |
|---|---|
| Drug class | Short-acting anticholinergic mydriatic/cycloplegic |
| Mechanism of action | Muscarinic antagonist; blocks the iris sphincter and ciliary muscle. Fastest onset and shortest duration of the anticholinergic mydriatics. |
| Indication / reason for use | Routine dilated fundus examination; weak cycloplegic refraction in adults/older children. |
| Usual adult dosing | 1 drop of 1% (repeat once at 5 min if needed); mydriasis in 15-30 min, recovery 4-8 h. Cycloplegia is incomplete. |
| Preservative | BAK 0.01% |
| Contact lenses | Remove lenses before instillation; reinsert once dilated / after 15 minutes. |
| Common / important adverse effects | Photophobia, blurred near vision, stinging; rare CNS effects in children (restlessness, flushing); can precipitate angle-closure in anatomically narrow angles. |
| Contraindications & cautions | Untreated narrow angles / prior angle-closure without patent iridotomy. Caution with Down syndrome and in infants (systemic sensitivity). |
| Pregnancy / lactation | Single diagnostic dose considered low risk; use punctal occlusion. |
| Pregnancy category (older labels) | No letter category on the current label. From DailyMed labels, checked Nov 2026. |
| Trade names | Mydriacyl, Tropicacyl |
| Practice notes | For a true cycloplegic refraction in a young hyperope, cyclopentolate or atropine is needed, tropicamide leaves too much accommodation. |
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.